Liver Biopsy is a diagnostic procedure for liver diseases, recommended when blood tests or diagnostic imaging might suggest a liver problem. It is of three major types namely percutaneous, transjugular, and laparoscopic. It is also used to monitor the liver condition during liver transplant and to determine complications if any. The healthcare provider may recommend liver biopsy if the patient is diagnosed with liver disease or identifies the presence of blood in the urine. The Global Liver Biopsy Market is expected to grow at a CAGR of ~4.2% during the forecast period 2017-2023.
Liver biopsy is a procedure for obtaining samples from kidney tissue for analysis. Liver biopsy is used to diagnose various liver diseases such as nonalcoholic fatty liver disease, chronic hepatitis B or C, autoimmune hepatitis, and alcoholic liver disease. Along with the diagnosis it is also used to monitor the effect of treatment and determine whether the kidney transplant is working well or not. It consists of mainly two types; percutaneous biopsy, transjugular, and laparoscopic. In a percutaneous biopsy, a needle is inserted into the kidney through the skin, while in the surgical biopsy, an incision is made in the skin near the liver to take a tissue sample for examination.
Liver Biopsy Market – Key Players
Some of key the players in the market are Becton, Dickinson and Company, MDxHealth, Veran medical, Medtronic, Argon Medical Devices, Inc., Mauna Kea Technologies, Boston Scientific Corporation, Intact Medical Corp., C. R. Bard, Inc., Leica Biosystems, Cook Medical, RI.MOS., Hologic, Inc., Sterylab, INRAD Inc., Fujifilm Medical Systems, and others.
Liver Biopsy Market – Intended Audience
- Research and Development (R&D) Companies
- Ambulatory Care Centers
- Academic Institutes and Universities
- Biotechnology Companies
- Medical Device Manufacturers
- Medical Device Suppliers
- Market Research and Consulting Service Providers
- Potential Investors
Click to Get Sample Report @
Liver Biopsy Market – Segmentation
The global liver biopsy market is segmented on the basis of type, indication, and end user.
On the basis of the diagnosis, it is segmented into percutaneous, transjugular, and laparoscopic biopsy.
On the basis of indication, it is segmented into nonalcoholic fatty liver disease, chronic hepatitis B or C, autoimmune hepatitis, alcoholic liver disease, and others.
Based on the end user, it is segmented into hospitals & clinics, tertiary care centers, urology centers, and others.
Liver Biopsy Market – Regional Analysis
Globally, the Americas is the largest market for liver biopsy due to increasing awareness about the importance of biopsy for the diagnosis of liver disease. In the Americas, North America is the largest market with the U.S. capturing major share followed by Canada. Additionally, extensive use of technologically advanced medical devices for diagnosis and treatment of chronic liver disease, support from the government for research & development, and high health care spending drives the market growth. Additionally, increasing patient population with liver disease, diabetes, and other risk factors for renal failure is fuelling the market growth.
Europe is the second largest market for liver biopsy whose growth is attributed to an increasing emphasis on the development of new diagnostic devices, favorable reimbursement policies, and investments in the development of new technologies for the treatment of chronic disease. Rising number of specialty services offered by various healthcare providers in Europe also accelerate the growth of the market. Additionally, rising government support for research & development, and availability of funds for research will fuel the market growth during the forecast period. As per the Lancet Liver Campaign report on liver diseases in the U.K., liver disease is the only major cause of death, which is expected to increase shortly. It also stated that use of alcohol is one of the major cause of various liver diseases among the adults. Furthermore, there is an increase in the hospital admissions for alcohol-related disease such as alcohol-related liver disease in various European nations also accelerates the market growth.
Get Unbelievable Discount on Report @ https://www.marketresearchfuture.com/check-discount/5534 .
The Asia Pacific is the fastest growing liver biopsy market owing to the ever-increasing prevalence of obesity, diabetes, and rising number of liver biopsy procedures in the hospital and surgical centers.
The Middle East & Africa exhibit steady growth in the liver biopsy market due to lack of funds, unavailability of technologically advanced medical devices, and limited medical facilities. In the Middle East, the United Arab Emirates (U.A.E) is the largest market owing to the progress of healthcare industry.
Major Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
List of Tables
Table 1 Liver Biopsy Industry Synopsis, 2017-2023
Table 2 Global Liver Biopsy Market Estimates and Forecast, 2017-2023, (USD Million)
Table 3 Global Liver Biopsy Market by Region, 2017-2023, (USD Million)
List of Figures
Figure 1 Research Process
Figure 2 Segmentation for Global Liver Biopsy Market
Figure 3 Segmentation Market Dynamics for Liver Biopsy Market
To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/5534 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312